Organization named in the records

Epidiolex

Named in 5 passages across 5 documents.

Mentions of Epidiolex in the public Epstein records, with citations.

Ask the documents about Epidiolex Search every mention

--}}

Being named in these documents is not an accusation or evidence of wrongdoing. This page reflects only what the public records literally contain, with citations to the original sources.

Where Epidiolex appears

5 total

an NDA for Epidiolex was submitted to the FDA in October 2017. If approved by

an NDA for Epidiolex was submitted to the FDA in October 2017. If approved by for Sativex p.1 View source release ↗

but not in the United States.) If the FDA approves Epidiolex

but not in the United States.) If the FDA approves Epidiolex 30 countries p.1 View source release ↗

44% of Epidiolex patients had at least a 50%

44% of Epidiolex patients had at least a 50% magnitudes of reduction. In particular p.1 View source release ↗

Epidiolex produced a median reduction in monthly drop

Epidiolex produced a median reduction in monthly drop older. On the primary endpoint p.1 View source release ↗

an NDA for Epidiolex was submitted to the FDA in October 2017. If approved by

an NDA for Epidiolex was submitted to the FDA in October 2017. If approved by mitted for Sativex p.1 View source release ↗

Want context across all of these passages at once?

Ask the documents about Epidiolex